HCA Healthcare (NYSE:HCA – Get Rating) had its target price reduced by Truist Financial from $310.00 to $250.00 in a report released on Monday, The Fly reports. Truist Financial’s price objective would suggest a potential upside of 16.90% from the stock’s previous close. A number of other research firms also recently weighed in on HCA. […]